Key facts
- This page summarizes Jennifer Balliet's Form 4 filing for NEOGENOMICS INC (NEO).
- 1 reported transaction and 6 derivative rows are listed below.
- Accepted by SEC: 30 Dec 2021, 17:03.
Jennifer Balliet - 30 Dec 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)
- Reporting relationship
- VP and Chief Culture Officer
- Issuer ticker
- NEO
- Reported as of
- 30 Dec 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 Dec 2021, 17:03:44 UTC
- Prior SEC filing
- 07 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/Jennifer Balliet
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jennifer Balliet filed Form 4 for NEOGENOMICS INC (NEO) on 30 Dec 2021.
Change
- Previous filing in this sequence was filed on 07 Jul 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEO
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +21,400
- Change %
- +79%
- Price
- $0.000000
- Shares after
- 48,615
- Date
- 30 Dec 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,000
- Date
- 30 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,000
- Exercise price
- $7.52
- Footnotes
- F2
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,334
- Date
- 30 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 33,334
- Exercise price
- $8.03
- Footnotes
- F3
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 17,496
- Date
- 30 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,496
- Exercise price
- $19.60
- Footnotes
- F4
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,006
- Date
- 30 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,006
- Exercise price
- $28.33
- Footnotes
- F5
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,551
- Date
- 30 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,551
- Exercise price
- $53.17
- Footnotes
- F6
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,050
- Date
- 30 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,050
- Exercise price
- $43.95
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
On December 30, 2021, Ms. Balliet was granted 21,400 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
Footnote F2
On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date.
Footnote F3
On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
Footnote F4
On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Footnote F5
On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Footnote F6
On March 2, 2021, Ms. Balliet was granted 10,551 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Footnote F7
On July 5, 2021, Ms. Balliet was granted 4,050 stock options. These options vest ratably over the first four anniversary dates of the grant date.